OA-05 Efficacy of forimtamig, a GPRC5DxCD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): analysis of patient and disease-related factors associated with responses

Simon J. Harrison, Caroline Hasselbalch Riley, Salomon Manier, Sung‐Soo Yoon, António Pinto, Titouan Cazaubiel, Anna Guidetti, Rakesh Popat, Cyrille Touzeau, Enrique M. Ocio, Fritz Offner, Paula Rodríguez‐Otero, Ilaria Rizzello, María‐Victoria Mateos, Ann-Marie E Bröske, Iryna Dekhtiarenko, Natalie Dimier, Jan Eckmann, Hans-Joachin Helms, Wolfgang Jacob, Meike Schneider, Nassim Sleiman, Maja Weisser, Carmelo Carlo‐Stella